WHO ICTRP trial

An open, single center, clinical investigation to evaluate the efficacy and…

ISRCTN78747508 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN78747508
Public title An open, single center, clinical investigation to evaluate the efficacy and safety of woman ISDIN Vaginal Moisturizer on symptomatic vaginal atrophy in post menopausal woman
Scientific title An open label, observational, non-interventional, unicentric, clinical investigation to evaluate the efficacy and safety of woman ISDIN Vaginal Moisturizer on symptomatic vaginal atrophy in 43 post menopausal woman during 12 weeks in the alleviation of vaginal atrophy symptoms
Primary sponsor Isdin (Spain)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Observational
Phase Not Applicable
Countries Spain
Conditions Efficacy and safety of Woman ISDIN® Vaginal Moisturizer in the alleviation of vaginal atrophy symptoms Skin and Connective Tissue Diseases
Interventions The treatment period will last 12 weeks for each patient, during which time they will use the investigational product as directed in the instructions. Therefore, it is expected to carry out 3 visits per patient at the investigational…
Registration date Jan 19, 2024
Target size 43
Secondary IDs Nil known;Nil known;ISD-WO-VAGINAL-01-2021
Registry page isrctn.com

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations